Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06543290 · ClinicalTrials.gov registry record · Phase 1
Azithromycin Before Induction
A Phase 1 study of Infections, sponsored by Arrowhead Regional Medical Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06543290: Recruiting Phase 1 study of Infections, sponsored by Arrowhead Regional Medical Center.
NCT06543290 is a Phase 1 study of Infections that is actively recruiting participants, run by Arrowhead Regional Medical Center. The registered enrollment target is 400 participants, below the 3,392-participant average among 26 other Infections trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06543290, a Phase 1 study of Infections, is actively recruiting participants, sponsored by Arrowhead Regional Medical Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.
Primary Outcome
single oral dose of Azithromycin given prior to the start of induction of labor will decrease rates of composite infection
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Azithromycin Pill
Study Locations (1)
California
- Arrowhead Regional Medical Center - Colton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-08-07 |
| Est. Completion | 2026-08-07 |
| Phase | Phase 1 |
What NCT06543290 shows while recruiting
NCT06543290 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 3,392-participant average among 26 other Infections trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Infections appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06543290 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06543290 about?
NCT06543290 is a clinical study titled "Azithromycin Before Induction". This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.
What is the current status of trial NCT06543290?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 400 participants. The study started on 2023-08-07. Estimated completion is 2026-08-07.
What conditions does trial NCT06543290 study?
This clinical trial studies the following conditions: Infections.
What interventions are being tested in trial NCT06543290?
The interventions under investigation include: Placebo (DRUG), Azithromycin Pill (DRUG).
Who is sponsoring clinical trial NCT06543290?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06543290 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06543290's enrollment target sits among peer trials
400 9th of 26 higher than 18 of 26 other Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RECRUITING · Phase 1
-
Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients
COMPLETED · Phase 1
-
The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers
COMPLETED · Phase 1
-
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
RECRUITING · NA
-
Remote Sputum Collection in Cystic Fibrosis
RECRUITING
-
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI